Guangdong Hybribio Biotech Co Ltd - ESG Rating & Company Profile powered by AI
This webpage includes a questions and answers section on Guangdong Hybribio Biotech Co Ltd. If you are employed by Guangdong Hybribio Biotech Co Ltd and you would like to use your Sustainability rating, please get in touch. Browse to the end of this page for potential risks for Guangdong Hybribio Biotech Co Ltd based on sector, geography and size.
Guangdong Hybribio Biotech Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Guangdong Hybribio Biotech Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Guangdong Hybribio Biotech Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Guangdong Hybribio Biotech Co Ltd disclose current and historical energy intensity?
Does Guangdong Hybribio Biotech Co Ltd report the average age of the workforce?
Does Guangdong Hybribio Biotech Co Ltd reference operational or capital allocation in relation to climate change?
Does Guangdong Hybribio Biotech Co Ltd disclose its ethnicity pay gap?
Does Guangdong Hybribio Biotech Co Ltd disclose cybersecurity risks?
Does Guangdong Hybribio Biotech Co Ltd offer flexible work?
Does Guangdong Hybribio Biotech Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Guangdong Hybribio Biotech Co Ltd disclose the number of employees in R&D functions?
Does Guangdong Hybribio Biotech Co Ltd conduct supply chain audits?
Does Guangdong Hybribio Biotech Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Guangdong Hybribio Biotech Co Ltd conduct 360 degree staff reviews?
Does Guangdong Hybribio Biotech Co Ltd disclose the individual responsible for D&I?
Does Guangdong Hybribio Biotech Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Guangdong Hybribio Biotech Co Ltd disclose current and / or historical scope 2 emissions?
Does Guangdong Hybribio Biotech Co Ltd disclose water use targets?
Does Guangdong Hybribio Biotech Co Ltd have careers partnerships with academic institutions?
Did Guangdong Hybribio Biotech Co Ltd have a product recall in the last two years?
Does Guangdong Hybribio Biotech Co Ltd disclose incidents of discrimination?
Does Guangdong Hybribio Biotech Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Guangdong Hybribio Biotech Co Ltd issued a profit warning in the past 24 months?
Does Guangdong Hybribio Biotech Co Ltd disclose parental leave metrics?
Does Guangdong Hybribio Biotech Co Ltd disclose climate scenario or pathway analysis?
Does Guangdong Hybribio Biotech Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Guangdong Hybribio Biotech Co Ltd disclose the pay ratio of women to men?
Does Guangdong Hybribio Biotech Co Ltd support suppliers with sustainability related research and development?
Does Guangdong Hybribio Biotech Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Guangdong Hybribio Biotech Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Guangdong Hybribio Biotech Co Ltd involved in embryonic stem cell research?
Does Guangdong Hybribio Biotech Co Ltd disclose GHG and Air Emissions intensity?
Does Guangdong Hybribio Biotech Co Ltd disclose its waste policy?
Does Guangdong Hybribio Biotech Co Ltd report according to TCFD requirements?
Does Guangdong Hybribio Biotech Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Guangdong Hybribio Biotech Co Ltd disclose energy use targets?
Does Guangdong Hybribio Biotech Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Guangdong Hybribio Biotech Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Guangdong Hybribio Biotech Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Guangdong Hybribio Biotech Co.,Ltd. was founded in 2003 and is based in Sheung Wan, Hong Kong.